台股 » 個股 » 智基 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智基

(6294)
可現股當沖
  • 股價
    59.7
  • 漲跌
    ▼0.3
  • 漲幅
    -0.50%
  • 成交量
    38
  • 產業
    上櫃 文化創意指數▲0.65%
  • 105人加入追蹤

    立即追蹤

  • 本地時間:13:35(已收盤)

     
智基 (6294)籌碼相關-元大-南京 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-南京 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/20158.8000.0059.501911.09%
2025/01/17758.9400.0058.807917.66%
2025/01/16359.1000.0059.003913.28%
2025/01/15159.0000.0059.001911.09%
2025/01/14159.1000.0059.001911.09%
2025/01/09459.9500.0060.104914.38%
2025/01/08460.4000.0060.404904.42%
2025/01/07360.6000.0060.803903.33%
2025/01/06160.6000.0060.601901.11%
2025/01/03260.6500.0060.602902.22%
2025/01/02260.5500.0060.702902.21%
2024/12/30261.0000.0060.802902.21%
2024/12/23160.5000.0061.401901.10%
2024/12/20160.5000.0060.801901.10%
2024/12/19160.6000.0061.001901.10%
2024/12/1700.00161.0060.70-191-1.10%
2024/12/16161.0000.0062.101901.10%
2024/12/12163.3000.0063.801891.12%
2024/12/09166.4000.0066.401941.06%
2024/12/05165.3000.0065.201951.05%
2024/12/03264.9500.0065.602972.05%
2024/11/29164.0000.0064.901981.02%
2024/11/28163.2000.0063.701981.01%
2024/11/21762.8300.0063.307947.42%
2024/11/203065.950.565.5064.4029.59132.32%
2024/11/19669.0200.0069.306886.75%
2024/11/18269.65371.1070.70-190-1.10%
2024/11/15270.9500.0072.6021011.96%
2024/11/141171.49170.3069.70101029.71%
2024/11/13977.7300.0077.409979.19%
2024/11/12286.90186.0086.001901.11%
2024/10/01297.0000.0097.1021381.44%
2024/09/201096.3400.0096.30101397.15%
2024/09/11395.9000.0096.1031392.15%
2024/09/0600.00199.6099.50-1137-0.73%
2024/09/0300.001101.50100.50-1139-0.72%
2024/08/191105.5017107.59106.00-16130-12.29%
2024/08/1600.0024105.25105.00-24118-20.20%
2024/08/1500.009104.89102.50-9114-7.85%
2024/08/1400.0020104.15104.50-20112-17.74%
2024/08/131101.5013104.92101.50-12109-10.99%
2024/08/121103.501103.00102.500990.00%
2024/08/060.198.7000.00100.000.1900.11%
2024/08/05598.6600.0098.805895.57%
2024/08/029100.5000.00100.5098810.20%
2024/07/262100.5000.00101.002892.22%
2024/07/231100.5000.00101.501901.11%
2024/07/222100.5000.00101.002902.21%
2024/07/1912101.0000.00101.50128913.35%
2024/07/114101.0000.00101.504944.23%
2024/07/103101.0000.00101.003993.03%
2024/07/091101.0000.00101.5011010.98%
2024/07/041100.502101.25102.50-1128-0.78%
2024/06/286100.5000.00100.5061364.41%
2024/06/276100.5000.00100.5061364.40%
2024/06/266100.5000.00100.5061374.37%
2024/06/255100.5000.00101.0051373.64%
2024/06/2410100.5000.00100.50101397.17%
2024/06/2111100.5000.00100.50111407.84%
2024/06/2012100.5000.00101.00121428.45%
2024/06/196100.5000.00101.0061434.19%
2024/06/188100.5600.00101.0081455.52%
2024/06/1719101.0000.00101.001914612.97%
2024/06/131100.5000.00100.5011520.66%
2024/06/126100.5800.00101.0061553.87%
2024/06/071102.5000.00102.5011550.64%
2024/05/2214102.501103.00103.00131578.26%
2024/05/211102.0000.00102.0011550.64%
2024/05/171105.001107.50105.5001520.00%
2024/05/1500.007104.29104.00-7148-4.72%
2024/05/143397.5623101.13102.00101446.92%
2024/05/135107.0000.00107.0051273.93%
2024/04/1700.003117.00117.00-3111-2.68%
2024/04/163113.002114.75114.0011110.90%
2024/04/102127.00122126.15127.00-12095-125.31% 大賣/鉅額交易
2024/04/0900.0014123.89124.00-1477-18.14%
2024/04/0800.0015123.70123.50-1573-20.43%
2024/04/0200.0010123.35123.50-1070-14.14%
2024/04/0100.0012122.92123.00-1269-17.24%
2024/03/290122.0011122.14122.00-1168-16.13%
2024/03/2800.0012122.25122.50-1267-17.91%
2024/03/270.2122.503122.00122.00-2.866-4.26%
2024/03/2600.002123.50123.00-263-3.13%
2024/03/2500.0010123.55124.00-1062-15.96%
2024/03/2200.0010124.00122.50-1060-16.60%
2024/03/2100.004122.25121.50-458-6.83%
2024/03/2000.0021121.86121.50-2156-37.12%
2024/03/1800.0021123.29124.00-2151-41.02%
2024/03/153120.6737121.08121.50-3447-72.19%
2024/03/140.5120.0041119.22119.00-40.543-93.53%
2024/03/1300.001117.00116.50-139-2.55%
2024/03/1200.0019117.03117.00-1938-48.91%
2024/03/1100.0010114.50114.50-1036-27.66%
2024/03/081113.505114.00113.50-434-11.49%
2024/02/1500.000.5111.50112.00-0.531-1.60%
慧智基因前列腺癌基因檢測套組 推行至國內千名患者Anue鉅亨-2021/09/14
疫情推升醫材需求強 雃博5月營收創同期高 慧智基因寫新猷Anue鉅亨-2021/06/10
智基 相關文章
智基 相關影音